Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 30, 2009


RXi Pharmaceuticals has appointed Richard Chin to its board of directors.

Chin is currently CEO of non-profit pharmaceutical company OneWorld Health. He previously served in various positions at OxiGene, Elan, and Genentech. He holds a BA in biology from Harvard University and a law degree from Oxford University.

Dicerna Pharmaceuticals announced that the Proceedings of the National Academy of Sciences' editorial board has awarded company co-founder and City of Hope researcher John Rossi has been awarded the 2008 Cozzarelli Prize.

Rossi received the award for his work on a publication entitled, "MicroRNA-Directed Transcriptional Gene Silencing in Mammalian Cells," the company said.

Opko Health has appointed Alice Lin-Tsing to its board of directors, according to a company filing with the US Securities and Exchange Commission.

Lin-Tsing is a researcher at the Genomics Research Center, Academia Sinica, in Taiwan. She is also a professor at the National Taiwan University and University of California, San Diego.

Benitec announced that Kenneth Reed, a non-executive director and company co-founder, has resigned from the firm's board. He remains the chair of Benitec's scientific advisory board.

According to the company, Reed stepped down in order to continue on as a researcher at the City of Hope.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.